XML 94 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2012
Business Combinations [Abstract]  
Summarizes the purchase prices and opening balance sheets for the acquisitions
 
Preliminary Allocation of Consideration Transferred as of December 31, 2012
Measurement Period Adjustments
Final Allocation of Consideration Transferred
Purchase consideration:
(In thousands)
Cash consideration
$
908,181

 
$
908,181

Fair value of Molycorp common stock and Exchangeable Shares issued
284,144

 
284,144

Total purchase consideration
$
1,192,325

 
$
1,192,325

Estimated fair values of the assets and liabilities acquired:
 
 
 
Cash and cash equivalents
$
317,169

$
—

$
317,169

Restricted cash
4,951

—

4,951

Accounts receivable
101,470

—

101,470

Inventory
250,989

—

250,989

Prepaid expenses and other current assets
26,893

—

26,893

Property, plant and equipment
75,745

—

75,745

Investments
21,019

(1,091
)
19,928

Intangibles
482,234

—

482,234

Deferred tax charges
13,435

—

13,435

Deferred tax assets
11,473

(1,423
)
10,050

Goodwill
494,809

31,616

526,425

Other non-current assets
4,367

—

4,367

Accounts payable and accrued expenses
(138,576
)
—

(138,576
)
Debt
(255,338
)
—

(255,338
)
Other current liabilities
(33,990
)
—

(33,990
)
Deferred tax liabilities
(154,309
)
5,880

(148,429
)
Other non-current liabilities
(14,255
)
—

(14,255
)
Non-controlling interests
(15,761
)
(34,982
)
(50,743
)
Total purchase consideration
$
1,192,325

$
—

$
1,192,325

The following table summarizes the purchase prices and opening balance sheets for the acquisition of 90.023% controlling interest in Molycorp Silmet on April 1, 2011 and of MMA on April 15, 2011 (in thousands):
(In thousands)
Molycorp Silmet
April 1, 2011
 
MMA
April 15, 2011
Purchase consideration:
 
 
 
Cash consideration
$
9,021

 
$
17,500

Fair value of Molycorp common stock issued
72,653

 
—

Total purchase consideration
$
81,674

 
$
17,500

Fair values of the assets and liabilities acquired:
 
 
 
Cash
$
105

 
$
6,395

Accounts receivable and other current assets
8,626

 
5,474

Inventory
37,404

 
11,327

Property, plant and equipment, net
63,393

 
4,512

Intangible assets subject to amortization
2,669

 
—

Goodwill
1,455

 
1,977

Liabilities
(19,974
)
 
(8,989
)
Deferred tax liabilities
—

 
(3,196
)
Long-term debt
(3,184
)
 
—

Noncontrolling interest
(8,820
)
 
—

Total purchase consideration
$
81,674

 
$
17,500

Summary of actual and pro forma information
The amounts of Molycorp Canada's revenues, earnings and earnings per share included in the Company’s consolidated statements of operations since the acquisition date, and the revenues, earnings and earnings per share of the combined entity had the acquisition date been January 1, 2011, were as follows:


(In thousands, except per share amounts)    
Revenues
 
Net Income (Loss)
 
Net Income (Loss)
Attributable To Molycorp
 
EPS Basic
Actual June 11, 2012 to December 31, 2012 (acquiree)
$
307,918

 
$
(338,347
)
 
$
(344,173
)
 
$
(3.21
)
Unaudited pro forma January 1, 2012 to December 31, 2012 (combined entity)
$
863,728

 
$
(463,716
)
 
$
(473,249
)
 
$
(4.53
)
Unaudited pro forma January 1, 2011 to December 31, 2011 (combined entity)
$
1,196,876

 
$
241,903

 
$
231,772

 
$
2.66

The pro forma revenues, earnings and earnings per share of the Company had both acquisitions occurred on January 1, 2011, were as follows:
(In thousands, except per share amounts)
Revenues
 

Net Income
 
Net Income
Attributable To
Molycorp
 
EPS Basic
Unaudited pro forma January 1, 2011 to December 31, 2011 (combined entity)
$
430,305

 
$
105,397

 
$
104,590

 
$
1.13

Unaudited pro forma January 1, 2010 to December 31, 2010 (combined entity)
$
85,549

 
$
(30,920
)
 
$
(31,329
)
 
$
(0.50
)
Schedule of Business Acquisitions, Transaction Costs by Type
For the year ended December 31, 2012, the Company recognized approximately $62.0 million of transaction costs related to the Molycorp Canada acquisition in the consolidated statement of operations and comprehensive income as follows (in thousands):    
Corporate development
 
    Legal, accounting and advisory fees
$
16,498

Other expenses:
 
    Contingent forward contract loss
$
37,589

Interest expense:
 
Bridge loan fee
$
7,937